The PRECISE-DIET Trial
Key facts
- Who runs it
- Steno Diabetes Center Copenhagen
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 130 people, planned
- Starts
- Feb 2027
- Expected to end
- Mar 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Personalised dietary intervention
- Standard dietary counselling
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- T2D
- Diabetes duration of ≥12 months
- Age ≥18 years
- HbA1c ≥58 mmol/mol
- Attending the SDCC outpatient clinic
- Provided voluntary signed informed consent
Who cannot take part
- Use of insulin therapy
- Low daily carbohydrate intake (defined as below 25 E% or 100 g/day) prior to study inclusion
- Systematic use of corticosteroids
- Known or suspected drug or alcohol abuse
- Initiation of GLP-1 receptor agonist or SGLT inhibitor therapy within the previous 3 months
- Using or requiring a specialised diet (e.g., protein restriction in kidney disease)
- Medical complications that prevent lowering HbA1c to below 58 mmol/mol
- Circumstances that affect HbA1c (e.g., liver disease and anaemia)
- Inability to understand the study information
- Pregnancy or breastfeeding or plans of pregnancy within the study period
- Participation in other clinical trials
- Individuals with a BMI of <27 kg/m²
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
People with type 2 diabetes receive standard dietary advice to improve glycaemic control. However, blood glucose responses to the same foods can vary considerably between individuals. This randomised controlled trial aims to investigate whether personalised carbohydrate recommendations guided by continuous glucose monitoring (CGM) improve glycaemic control (HbA1c) compared with standard dietary care.
Read full original descriptionShow less
A total of 130 adults with type 2 diabetes will be randomly assigned to one of two groups. The study will include a 6-month intervention period followed by a 6-month follow-up period. The intervention group will receive dietitian-led personalised carbohydrate recommendations informed by CGM data, supplemented by group-based education in carbohydrate counting. The control group will receive standard individual dietary counselling provided by a dietitian without the use of CGM.
The primary outcome is the between-group difference in change in HbA1c from baseline to 6 months.
The 2 groups in the trial
- Personalised dietary interventionTreatment being tested
CGM-supported personalised carbohydrate recommendations
- Standard dietary counsellingExisting treatment, for comparison
Standard dietary counselling for type 2 diabetes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Precision Nutrition Versus Standard Dietary Care: Effect of Personalised Nutrition Guidance Based on Continuous Glucose Monitoring in Type 2 Diabetes - The PRECISE-DIET Trial
- Record updated
- 16 November 2026